Capital Factory
← Portfolio
Asclepii logo

Asclepii

Turning a $30K regenerative therapy into $300

Texas Fund I

What is Asclepii? – Asclepii is a company reinventing the future of tissue engineering, starting with our product called Artemis What is Artemis? – Artemis is an innovative extracellular matrix (ECM) that has a pre-integrated proprietary growth factor that creates unprecedented levels of cellular adhesion, cellular kinetics, and coagulation in mere minutes. This discovery also allows integration of therapeutics directly into the Artemis matrix How Does it Work? – Artemis is a shelf-stable, durable extracellular matrix (ECM) that can be placed on any damage of the skin: whether it be acute/chronic, burn, ulcer, impact injury, or incision. This allows Artemis to be used for wound care in almost any setting for almost any indication where wound healing or tissue regeneration would be beneficial, at minimal cost to the patient

Sector
Healthcare, Pharmaceuticals & Medicine, Clinical Trials
Founded
2022
Team
13
Backed by
Texas Fund I